NCT06330675

Brief Summary

Bedrest is usually prescribed for patients management after cardiac electronic device implantation (CIED) in order to prevent complication. Due to the lack of guidelines available on the timing of postoperative mobilization management, the aim of the study is to evaluate the safety of early mobilization, comparing mobilization at 4-h against day-after procedure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
558

participants targeted

Target at P75+ for not_applicable

Timeline
13mo left

Started Feb 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Feb 2023Jun 2027

Study Start

First participant enrolled

February 1, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 19, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

4 years

First QC Date

March 19, 2024

Last Update Submit

August 8, 2025

Conditions

Keywords

PacemakerImplantable cardioverter-defibrillatorEarly mobilizationBed-rest

Outcome Measures

Primary Outcomes (1)

  • Composite endpoint: pacing lead dislodgement, pocket hematoma, pneumothorax, and pericardial effusion

    Incidence of post-operatory complications (composite endpoint). Non inferiority margin 5%

    Within 48 hours post operative

Secondary Outcomes (7)

  • Post-operative pain

    24 hours

  • Sleep disturbance

    The first night after surgery

  • Number of participants with postoperative urinary retention

    Within 24 hours post operative

  • Number of participants developing postoperative delirium

    Within 24 hours post operative

  • Number of participants developing orthostatic intolerance

    First out-of-bed mobilization

  • +2 more secondary outcomes

Other Outcomes (1)

  • Incidence of pacing lead dislodgement, pocket hematoma, pneumothorax, pericardial effusion, and pocket infection

    3 month

Study Arms (2)

Mobilization 4-h after procedure

EXPERIMENTAL

Short-term bed-rest (4-h) after CIED implantation

Other: Early mobilization

Mobilization day-after procedure

ACTIVE COMPARATOR

Standard of care with prolungate bed-rest after CIED implantation

Other: Standard of care

Interventions

Short-term bed-rest and immobilization

Mobilization 4-h after procedure

Bed-rest and immobility until the day-after procedure

Mobilization day-after procedure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 18 years old
  • Signed informed consent form
  • New permanent pacemaker implantation (PM) or implantable cardioverter-defibrillator (ICD)

You may not qualify if:

  • CIED implants after recent cardiac surgery
  • Upgrade or revision of implanted device
  • CRT implantation
  • Intraoperative complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiocentro Ticino Institute - EOC

Lugano, 6900, Switzerland

RECRUITING

MeSH Terms

Interventions

Early AmbulationStandard of Care

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Elena Caporali, MD

    Cardiocentro Ticino Institute - EOC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 19, 2024

First Posted

March 26, 2024

Study Start

February 1, 2023

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations